Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01772329 · ClinicalTrials.gov registry record · NA

Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects

A NA study of Catastrophization, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
160
Enrollment target
1
Study location

NCT01772329 is a NA study of Catastrophization that has completed, run by Rush University Medical Center. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01772329, a NA study of Catastrophization, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

The investigators propose a randomized controlled trial to evaluate the effects of treatment intended to reduce pain catastrophizing among patients reporting high pain catastrophizing prior to total knee replacement(TKR), total hip replacement(THR), or shoulder surgery in an effort to thereby reduce the incidence of persistent post-surgical pain (PPP) and enhance physical function at 3-months post-surgery. Preemptive treatment aimed at a known predictor of PPP following total knee replacement is highly innovative and have potentially high impact for public health. Cognitive therapy is a well-tolerated modality among chronic pain patients with few if any side effects. Cognitive therapy (CT) represents an inexpensive method that could greatly reduce suffering and costly post-surgical pain management for high risk TKR patients.

Conditions Studied

Interventions

  • OTHER Routine Care
  • OTHER Cognitive Therapy

Study Locations (1)

Illinois

  • Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2013-01
Est. Completion 2020-10
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT01772329

The ClinicalTrials.gov registry entry for NCT01772329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Catastrophization appearing as the primary indexed condition, and to 2 interventions - of which Routine Care is the first listed.

NCT01772329 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01772329 about?

NCT01772329 is a clinical study titled "Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects". The investigators propose a randomized controlled trial to evaluate the effects of treatment intended to reduce pain catastrophizing among patients reporting high pain catastrophizing prior to total knee replacement(TKR), total hip replacement(THR), or shoulder surgery in an effort to thereby reduce...

What is the current status of trial NCT01772329?

This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2013-01. Estimated completion is 2020-10.

What conditions does trial NCT01772329 study?

This clinical trial studies the following conditions: Catastrophization.

What interventions are being tested in trial NCT01772329?

The interventions under investigation include: Routine Care (OTHER), Cognitive Therapy (OTHER).

Who is sponsoring clinical trial NCT01772329?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01772329 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.